Yat Sun Or,Ruichao Shen,Peng Dai,Jiang Long,Xuechao Xing,Guoqiang Wang
申请号：
US14952526
公开号：
US10519191B2
申请日:
2015.11.25
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to compounds of Formula (IA) and Formula (IB),and pharmaceutically acceptable salts thereof, where R1, R2, R3, R4, R5, R6, R7, R8, R9 and m are as defined herein, pharmaceutical compositions comprising these compounds and methods of use of these compounds for treating a TGR5 mediated disease or condition.
